glp 1 drugs history of glucagon-like peptide-1 receptor agonists Safety and Tolerability of Glucagon-Like
Description
The field is moving quickly, and the clinical frameworks around these medications are still maturing
Louis (MO): Mosby
[DOI] [PubMed] [Google Scholar] 384.Challa T.D., Beaton N., Arnold M., Rudofsky G., Langhans W., Wolfrum C
Need help from an expert
processed cryo-EM data, modeled, refined and analyzed the structure, wrote manuscript with input from all authors
